Pioglitazone  + Glimepiride Tablets

Pioglitazone + Glimepiride Tablets

Form: Tablets

Strength: Pioglitazone 15 mg/30 mg + Glimepiride 1 mg/2 mg/ 4 mg

Reference Brands: Duetact

Category: Diabetes

Pioglitazone and Glimepiride combination tablets are used in managing type 2 diabetes mellitus by enhancing insulin sensitivity and stimulating pancreatic insulin secretion. In the USA, fixed-dose combinations are less commonly marketed, with Actoplus Met (Pioglitazone + Metformin) being more prevalent. However, some Pioglitazone–Glimepiride formulations are approved in select EU countries and widely available as generics in Asia. In the EU, products must meet EMA standards for bioequivalence and fixed-dose rationale. These combinations are prescribed when monotherapy fails to control blood glucose. Pharmatradz.com connects buyers with certified suppliers offering GMP-compliant combination antidiabetic medications globally, including Pioglitazone-Glimepiride tablets.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Premixed Insulins (70/30, 50/50) Injectable

Strength: U-100

Form: Vials, pens

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

View Details Get Enquiry
Insulin Lispro (Humalog) injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)

View Details Get Enquiry
Insulin Aspart (Novolog) injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Novolog, Fiasp(US &EU)

View Details Get Enquiry
Insulin Glargine (Lantus) injectable

Strength: U-100, U-300

Form: Vials/pens

Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.